Deep sequencing of peripheral blood plasma DNA is reliable for confirming the diagnosis of myelodysplastic syndrome

摘要

Methods are provided for treating, managing, diagnosing and monitoring myelodysplastic syndrome and other hematologic malignancies. These methods comprise the next generation sequencing analysis conducted on cell-free DNA from peripheral blood plasma or serum.